STOCK TITAN
  1. Home
  2. News
  3. PAHC

Phibro Animal Health Corp. - PAHC STOCK NEWS

Welcome to our dedicated news page for Phibro Animal Health (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Phibro Animal Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Phibro Animal Health's position in the market.

News
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Rhea-AI Summary
Phibro Animal Health (PAHC) will release its third-quarter financial results on May 8, 2024, followed by a conference call and webcast on May 9, 2024. Interested parties can access the call and presentation slides online or via phone.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
conferences earnings
-
News
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) will participate in the Barclays Global Healthcare Conference with its CFO and COO presenting to analysts and investors. The event will take place on March 12, 2024, at 4:35 PM ET in Miami Beach. The presentation will be available live and archived on the company's Investor Relations Website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
conferences
-
News
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) to participate in Bank of America 2024 Virtual Animal Health Summit with CFO and EVP Corporate Strategy presenting to financial analysts and investors. The live audio presentation will be on February 29, 2024, at 10:00 AM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
conferences
News
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) announced its Q2 financial results, showing a 2% increase in net sales to $249.9 million and a 5% decrease in adjusted EBITDA to $29.5 million. The company affirmed its fiscal year 2024 guidance for net sales and adjusted EBITDA, but updated its guidance for net income and diluted EPS, reflecting recent developments such as expenses for Brazil employment taxes and foreign currency losses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.4%
Tags
earnings
-
News
Phibro Animal Health Corporation Declares Quarterly Dividend
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) has declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on March 27, 2024, to stockholders of record at the close of business on March 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
dividends
-
News
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) announced the appointment of Glenn C. David as Chief Financial Officer, effective February 9, 2024. Mr. David brings over 30 years of experience in commercial and financial leadership roles, with his most recent role being Executive Vice President and Group President, US Operations, Diagnostics, Biodevices, and Insurance at Zoetis Inc. Phibro's Chairman, President, and CEO, Jack Bendheim, expressed excitement about David's appointment, highlighting his wealth of knowledge and experience in the animal health industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
News
Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) will release its second quarter financial results on February 7, 2024, after the market closes. A conference call and webcast will be hosted on February 8, 2024, at 9:00 AM Eastern Time. Interested parties can access the call and presentation slides at https://investors.pahc.com or by dialing the provided phone numbers. A webcast replay will be available after the live event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
conferences earnings
-
News
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
Rhea-AI Summary
Phibro Animal Health Corporation (Nasdaq: PAHC) announced Q1 financial results, showing a 1% decrease in net sales to $231.3 million and a net loss of $8.0 million. Adjusted EBITDA decreased by 16% to $18.7 million. The company updated its fiscal year 2024 guidance, expecting net sales of $980 million to $1.02 billion and adjusted EBITDA of $106 million to $112 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.52%
Tags
earnings
-
News
Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers
Rhea-AI Summary
Phibro Animal Health Corporation (NASDAQ: PAHC) has received two actions from the FDA regarding Mecadox® (carbadox). The FDA has issued a final order to revoke the approved method for detecting residues of carbadox and proposed to withdraw approval of all new animal drug applications providing for the use of carbadox in medicated swine feed. Phibro believes in the safety of Mecadox and is disappointed in the FDA's actions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
News
Phibro Animal Health Corporation Declares Quarterly Dividend
Rhea-AI Summary
Phibro Animal Health Corporation (Nasdaq:PAHC) has declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock. The dividend is payable on December 20, 2023, to stockholders of record as of November 29, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
dividends
Stock PAHC logo
Phibro Animal Health Corp.

Nasdaq:PAHC

PAHC Rankings

#2961 Ranked by Market Cap
#3687 Ranked by Stock Gains
#893 Ranked by Dividends

PAHC Stock Data

531.00M
20.20M
0.63%
103.19%
1.74%
Medicinal and Botanical Manufacturing
Manufacturing
Link
US
Teaneck

About PAHC

phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our